Clinical trial Recruiting at 5 sites Phase 3 Interventional Ages 18 and up

Using a fat emulsion to identify bile ducts during liver surgery to prevent bile leakage

Official title: Diagnostic Role of the "White Test" With Lipidic Solution in the Early Intraoperative Identification of Open Bile Ducts for the Prevention of Bile Leakage After Liver Resection- A Randomized Controlled Multicentric Superiority Trial- The BiLe-Trial (Bile Leakage Trial)

Run by Kantonsspital Aarau · NCT04523701 · Data updated 2026-11-12

This study is testing whether a special fat solution can help doctors see bile ducts better during liver surgery to prevent leaks and improve recovery for patients.

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment210 (estimated)
SponsorKantonsspital Aarau
Academic / other
Locations5 sites (Aarau and 4 other locations)
StatusRecruiting
StartedMarch 25, 2021
Main results expectedDecember 2025
Study endsDecember 2025
Registry record updatedMarch 14, 2025
Trial IDNCT04523701 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients scheduled for anatomical resection of two or more liver segments with simultaneous cholecystectomy.

Probably not a fit

Patients who have had a previous cholecystectomy where the cystic stump cannot be identified intraoperatively may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the use of SMOFlipid 20%, a fat emulsion, administered retrograde through the cystic duct during liver resection surgeries. The goal is to enhance the intraoperative identification of open bile ducts, which can then be sutured to prevent bile leakage, a common complication following liver surgery. By reducing the incidence of bile leakage, the study aims to decrease the need for additional interventions and improve patient outcomes within 30 days post-surgery. The trial will include patients undergoing anatomical liver resections with simultaneous cholecystectomy.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the rate of bile leakage after liver resection, leading to better recovery and fewer complications for patients.

How similar studies have gone: While the use of fat emulsions in surgical settings is not widely tested, the innovative approach of using SMOFlipid for bile duct identification represents a novel strategy that could lead to significant advancements in surgical outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients who will receive an anatomical resection of two or more liver segments for any reason with simultaneous cholecystectomy in elective Setting
* Patients who will receive an anatomical resection of two or more liver segments for any reason which already had a cholecystectomy if intraoperatively the cystic stump can be identified and opened
* Ability of subject to understand character and individual consequences of the clinical Trial
* Informed consent documented by signature

Exclusion Criteria:

* Previous cholecystectomy if intraoperative it is not possible to identify the cystic stump
* Intraoperative hepatico-jejunostomy
* Hypersensitivity to fish-, egg-, soybean or peanut protein or to any of the active ingredients or excipients
* Immunosuppression, pregnancy
* Emergency liver resection because of traumatic liver rupture
* Enrolment of the investigator, his/her family members, employees and other dependent persons

Where it's running

  • Department of Visceral Surgery, Cantonal Hospital of Aarau
    Aarau, Switzerland
    Recruiting
  • Clarunis Basel, Universitäres Bauchzentrum Basel
    Basel, Switzerland
    Recruiting
  • Kantonsspital Luzern
    Lucerne, Switzerland
    Recruiting
  • Ospedale Regionale di Lugano
    Lugano, Switzerland
    Recruiting
  • Kantonsspital St. Gallen
    Sankt Gallen, Switzerland
    Recruiting

Study contacts

  • Principal investigator: Giulia Manzini, Dr. med. — Cantonal Hospital of Aarau, Switzerland
  • Study coordinator: Giulia Manzini, Dr. med.
  • Email: giulia.manzini@ksa.ch
  • Phone: +41-62-8389734

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.